Agilent workshop on Data Integrity, compliance and Analytical technologies

Agilent workshop on Data Integrity, compliance and Analytical technologies

Data integrity issues in all over all over the world in Pharma Industry in India around 94% cases are registered for Data integrity and also in globally 90% Data integrity Data integrity issues are registered. India 16 API manufacturing pharmaceutical company out of 15 pharmaceutical company have registered warning letters regarding that Data integrity issues and in formulations and other 50 pharmaceutical company out of 12 pharmaceutical companies have registered Data integrity . Overall in India 93. 75% Data integrity issues register.” This was stated by Dr. Arvind Kukreti Deputy Drug Controller, CDSCO.

“Recent changes in drug regulation mandatory bioavailability and bioequivalence studies for BCS class 2 and class IV drugs. Mission of stability data for obtaining product permission from state licensing authority by Inspector soap CDSCO licensing authority check all the facilities once in 3 years mandatory registration of firms on SUGAM and online approval system”, he added. Dr. Viranchi Shah, President of IDMA_GSB also gave guidance to the delegates on Data Integrity, compliance and Analytical technologies and explained the importance of the topic in present context. Yagnik Patel from Accuprec Research Labs Pvt. Ltd. attended the training programme.